Most companies are likely going to feel the impact of President Trump's tariffs. In the video above, BofA Securities senior pharma & biotech analyst Tim Anderson describes how tariffs will impact the pharmaceutical stocks he covers. He also explains why Eli Lilly (LLY) and Novo Nordisk (NVO) have a "moat" around them. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.
OK